Cytokinetics | CYTK - Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Amgen USD 24.96B 534M 2026-03
Arca Biopharma USD 16.63M 1.26M 2026-03
Bayer EUR 33.46B 875M 2026-03
Biogen USD 3B 350.5M 2026-03
Brainstorm Cell Therapeutics USD 11.76M 757K 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Capricor Therapeutics USD 33.64M 2.2M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
Eisai JPY 340.25B 47.42B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Exelixis USD 370.98M 34.67M 2026-03
Geron USD 73.57M 40.25M 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Ligand Pharmaceuticals USD 40.67M 3.22M 2026-03
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03